Kiniksa Pharmaceuticals, Ltd. - (KNSA) Social Stream



Kiniksa Pharmaceuticals, Ltd. - (KNSA): $18.76

0.17 (-0.90%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add KNSA to Watchlist
Sign Up

KINIKSA PHARMACEUTICALS LTD (KNSA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering KNSA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-28 3 $37 $26 $30 $18.31 63.84%
2021-12-29 3 $34 $25.91 $28.97 $18.31 58.22%
2022-02-22 3 $34 $27 $29.666 $18.31 62.02%
2022-05-03 3 $28 $24 $25.666 $18.31 40.17%
2022-08-03 3 $28 $22 $25 $18.31 36.54%
2022-10-31 3 $28 $19 $24 $18.31 31.08%
2023-02-08 3 $28 $19 $24.333 $18.31 32.89%
2023-02-28 2 $28 $19 $24.333 $18.31 32.89%
2023-03-03 2 $28 $19 $22.333 $18.31 21.97%
2023-05-02 3 $28 $20 $22.666 $18.31 23.79%
2023-07-25 3 $28 $20 $23 $18.31 25.61%
2023-07-26 4 $32 $20 $25.75 $18.31 40.63%
2023-10-31 4 $32 $23 $26.75 $18.31 46.1%
2023-11-22 4 $32 $23 $26.5 $18.31 44.73%

The Trend in the Analyst Price Target


Over the past 29 months, KNSA's average price target has gone down $5.5.

KNSA reports an average of 65.32% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-08 2 28 19 24.333 13.77 76.71%
2023-03-03 3 28 19 22.333 12.28 81.86%
2023-05-09 3 28 20 23.000 13.76 67.15%
2023-08-09 4 32 23 26.750 17.48 53.03%
2023-11-22 4 32 23 26.500 15.79 67.83%

KNSA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


KNSA's average broker recommendation rating improved by 0 over the prior 15 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KNSA as an investment opportunity.

  • In the context of all US stocks, KINIKSA PHARMACEUTICALS LTD's number of analysts covering the stock is greater than 132.9% of them.
  • KNSA has a lower variance in analysts' estimates than -210.84% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, KINIKSA PHARMACEUTICALS LTD's upside potential (average analyst target price relative to current price) is higher than 467.66% of them.
  • In terms of how KINIKSA PHARMACEUTICALS LTD fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 1040.48% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KINIKSA PHARMACEUTICALS LTD are EOLS, OPTN, and SPRO.

What is the outlook for KNSA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!